{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=cohort+2&page=46",
    "query": {
      "intervention": "cohort 2",
      "page": 46
    },
    "page_size": 10
  },
  "pagination": {
    "page": 46,
    "page_size": 10,
    "total_count": 7390,
    "total_pages": 739,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=cohort+2&page=47&page_size=10",
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=cohort+2&page=45&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-11-19T08:30:45.544Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT05674175",
      "title": "Co-administration of CART22-65s and huCART19 for B-ALL",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "B-cell Acute Lymphoblastic Leukemia",
        "B Lineage Lymphoblastic Lymphoma"
      ],
      "interventions": [
        {
          "name": "Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Stephan Grupp MD PhD",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": "29 Years",
        "sex": "ALL",
        "summary": "Up to 29 Years"
      },
      "enrollment_count": 93,
      "start_date": "2023-01-25",
      "completion_date": "2029-07-01",
      "has_results": false,
      "last_update_posted_date": "2026-03-27",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 1,
      "location_summary": "Philadelphia, Pennsylvania",
      "locations": [
        {
          "city": "Philadelphia",
          "state": "Pennsylvania"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05674175"
    },
    {
      "nct_id": "NCT05894967",
      "title": "Moderators and Mediators of Perceptual Learning",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Cognitive Change"
      ],
      "interventions": [
        {
          "name": "C1 - Standard Perceptual Learning (SPL)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C2 - Long Training (LT)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C3 - Short Staircases (SS)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C4 - Mixed Difficulty (MD)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C5 - Noise Training (NT)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C6 - Training with Flankers (TWF)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C7 - Parafoveal Training (PT)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C8 - Stimulus Variety (SV)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C8a - Complex Features (CF)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C9 - Exogenous Attention Training (ExAT)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C10 - Endogenous Attention Training (EnAT)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "C11 - Multisensory Facilitation (MF)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "No Contact Control",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "University of Wisconsin, Madison",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "85 Years",
        "sex": "ALL",
        "summary": "18 Years to 85 Years"
      },
      "enrollment_count": 1140,
      "start_date": "2023-04-14",
      "completion_date": "2027-03-31",
      "has_results": false,
      "last_update_posted_date": "2025-12-15",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 3,
      "location_summary": "Riverside, California • Boston, Massachusetts • Madison, Wisconsin",
      "locations": [
        {
          "city": "Riverside",
          "state": "California"
        },
        {
          "city": "Boston",
          "state": "Massachusetts"
        },
        {
          "city": "Madison",
          "state": "Wisconsin"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05894967"
    },
    {
      "nct_id": "NCT04382898",
      "title": "PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)",
      "overall_status": "TERMINATED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Prostate Cancer"
      ],
      "interventions": [
        {
          "name": "BNT112",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cemiplimab",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL",
        "DRUG"
      ],
      "sponsor": "BioNTech SE",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "MALE",
        "summary": "18 Years and older · Male only"
      },
      "enrollment_count": 75,
      "start_date": "2019-12-19",
      "completion_date": "2024-01-23",
      "has_results": true,
      "last_update_posted_date": "2025-03-20",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 5,
      "location_summary": "Tucson, Arizona • Miami, Florida • Pittsburgh, Pennsylvania + 2 more",
      "locations": [
        {
          "city": "Tucson",
          "state": "Arizona"
        },
        {
          "city": "Miami",
          "state": "Florida"
        },
        {
          "city": "Pittsburgh",
          "state": "Pennsylvania"
        },
        {
          "city": "San Antonio",
          "state": "Texas"
        },
        {
          "city": "Charlottesville",
          "state": "Virginia"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04382898"
    },
    {
      "nct_id": "NCT01436487",
      "title": "Study to Examine the Effects of MultiStem in Ischemic Stroke",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Ischemic Stroke"
      ],
      "interventions": [
        {
          "name": "MultiStem",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Placebo",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Healios K.K.",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "83 Years",
        "sex": "ALL",
        "summary": "18 Years to 83 Years"
      },
      "enrollment_count": 134,
      "start_date": "2011-10",
      "completion_date": "2015-12",
      "has_results": false,
      "last_update_posted_date": "2016-08-02",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 26,
      "location_summary": "Los Angeles, California • Stanford, California • Miami, Florida + 20 more",
      "locations": [
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Stanford",
          "state": "California"
        },
        {
          "city": "Miami",
          "state": "Florida"
        },
        {
          "city": "Orlando",
          "state": "Florida"
        },
        {
          "city": "Augusta",
          "state": "Georgia"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01436487"
    },
    {
      "nct_id": "NCT07723833",
      "title": "A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Healthy Participants"
      ],
      "interventions": [
        {
          "name": "Elecoglipron Reference Formulation Dose A",
          "type": "DRUG"
        },
        {
          "name": "Elecoglipron Test formulation 1 Dose A",
          "type": "DRUG"
        },
        {
          "name": "Elecoglipron Reference Formulation Dose B",
          "type": "DRUG"
        },
        {
          "name": "Elecoglipron Test formulation 1 Dose B",
          "type": "DRUG"
        },
        {
          "name": "Elecoglipron Test formulation 2 Dose A",
          "type": "DRUG"
        },
        {
          "name": "Elecoglipron Test formulation 2 Dose B",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "AstraZeneca",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "55 Years",
        "sex": "ALL",
        "summary": "18 Years to 55 Years"
      },
      "enrollment_count": 152,
      "start_date": "2026-07-27",
      "completion_date": "2026-11-18",
      "has_results": false,
      "last_update_posted_date": "2026-09-16",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 2,
      "location_summary": "Glendale, California • Brooklyn, Maryland",
      "locations": [
        {
          "city": "Glendale",
          "state": "California"
        },
        {
          "city": "Brooklyn",
          "state": "Maryland"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT07723833"
    },
    {
      "nct_id": "NCT07920952",
      "title": "Effects of Ad Libitum Ultra-Processed Diet on Brain Dopamine in Humans",
      "overall_status": "NOT_YET_RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Healthy Volunteers"
      ],
      "interventions": [
        {
          "name": "[11C] raclopride",
          "type": "DRUG"
        },
        {
          "name": "liquid nutritive stimulus",
          "type": "OTHER"
        },
        {
          "name": "Tasteless Oral Stimulus Solution",
          "type": "OTHER"
        },
        {
          "name": "Minimally Processed Diet",
          "type": "OTHER"
        },
        {
          "name": "Ultra Processed Diet",
          "type": "OTHER"
        },
        {
          "name": "Baseline Diet",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DRUG",
        "OTHER"
      ],
      "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
      "sponsor_class": "NIH",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "45 Years",
        "sex": "ALL",
        "summary": "18 Years to 45 Years"
      },
      "enrollment_count": 140,
      "start_date": "2026-11-23",
      "completion_date": "2030-11-10",
      "has_results": false,
      "last_update_posted_date": "2026-11-18",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 1,
      "location_summary": "Bethesda, Maryland",
      "locations": [
        {
          "city": "Bethesda",
          "state": "Maryland"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT07920952"
    },
    {
      "nct_id": "NCT05508165",
      "title": "Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.",
      "overall_status": "SUSPENDED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Urologic Diseases"
      ],
      "interventions": [
        {
          "name": "Stream Dx",
          "type": "DEVICE"
        },
        {
          "name": "DFree",
          "type": "DEVICE"
        },
        {
          "name": "TestCard",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DEVICE"
      ],
      "sponsor": "Indiana University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 60,
      "start_date": "2022-08-30",
      "completion_date": "2026-12-30",
      "has_results": false,
      "last_update_posted_date": "2026-09-08",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 1,
      "location_summary": "Indianapolis, Indiana",
      "locations": [
        {
          "city": "Indianapolis",
          "state": "Indiana"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05508165"
    },
    {
      "nct_id": "NCT05298592",
      "title": "A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Cancer"
      ],
      "interventions": [
        {
          "name": "BMS-986406",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Nivolumab",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Carboplatin",
          "type": "DRUG"
        },
        {
          "name": "Pemetrexed",
          "type": "DRUG"
        },
        {
          "name": "Paclitaxel",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL",
        "DRUG"
      ],
      "sponsor": "Bristol-Myers Squibb",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 77,
      "start_date": "2022-03-31",
      "completion_date": "2024-08-16",
      "has_results": false,
      "last_update_posted_date": "2024-09-26",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 9,
      "location_summary": "Birmingham, Alabama • La Jolla, California • Los Angeles, California + 5 more",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        },
        {
          "city": "La Jolla",
          "state": "California"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Hackensack",
          "state": "New Jersey"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05298592"
    },
    {
      "nct_id": "NCT02877732",
      "title": "EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2",
      "overall_status": "TERMINATED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Eye-tracking"
      ],
      "interventions": [
        {
          "name": "EYE-SYNC eye-tracking",
          "type": "DEVICE"
        },
        {
          "name": "SCAT-3 subtests",
          "type": "OTHER"
        },
        {
          "name": "DEM",
          "type": "OTHER"
        },
        {
          "name": "Simple Reaction Time subtest of ANAM-SRT",
          "type": "OTHER"
        },
        {
          "name": "Level of Alertnesss",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DEVICE",
        "OTHER"
      ],
      "sponsor": "Stanford University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "25 Years",
        "sex": "ALL",
        "summary": "18 Years to 25 Years"
      },
      "enrollment_count": 12,
      "start_date": "2016-07",
      "completion_date": "2017-04",
      "has_results": true,
      "last_update_posted_date": "2018-05-30",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 4,
      "location_summary": "Los Angeles, California • Santa Barbara, California • Corvallis, Oregon + 1 more",
      "locations": [
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Santa Barbara",
          "state": "California"
        },
        {
          "city": "Corvallis",
          "state": "Oregon"
        },
        {
          "city": "Salt Lake City",
          "state": "Utah"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02877732"
    },
    {
      "nct_id": "NCT04998006",
      "title": "Alcohol and Cannabis Co-Use and the Gut-Brain Axis",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Cannabis Use",
        "Alcohol Use",
        "Inflammation"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "University of Colorado, Denver",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "21 Years",
        "maximum_age": "60 Years",
        "sex": "ALL",
        "summary": "21 Years to 60 Years"
      },
      "enrollment_count": 77,
      "start_date": "2022-02-25",
      "completion_date": "2024-12-23",
      "has_results": false,
      "last_update_posted_date": "2026-05-15",
      "last_synced_at": "2026-11-19T08:30:45.544Z",
      "location_count": 1,
      "location_summary": "Aurora, Colorado",
      "locations": [
        {
          "city": "Aurora",
          "state": "Colorado"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04998006"
    }
  ]
}